![Glenn Larsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Larsen
Algemeen Directeur bij
Aquinnah Pharmaceuticals, Inc.
Vermogen: 730 249 $ op 31-05-2026
Profiel
Glenn R.
Larsen is the founder of Aquinnah Pharmaceuticals, Inc., founded in 2014, serving as Chairman, President & Chief Executive Officer.
Dr. Larsen was the founder of 180 Therapeutics LP, founded in 2013, serving as Chairman from 2013 to 2020.
Former jobs include Senior Director at Genetics Institute LLC from 2003 to 2010; COO, Director & Executive VP-Development at Hydra Biosciences, Inc. from 2003 to 2010; Independent Director at Anika Therapeutics, Inc. from 2015 to 2026; Vice President at Wyeth Pharmaceuticals LLC; and CSO, Executive VP-Research & Development at SpringLeaf Therapeutics, Inc. from 2012 to 2013.
Education includes a doctorate from Stony Brook University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-04-2026 | 50.258 ( 0,38% ) | 730 249 $ | 31-05-2026 |
Actieve functies van Glenn Larsen
| Bedrijven | Functie | Begin |
|---|---|---|
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Algemeen Directeur | 01-02-2014 |
Eerdere bekende functies van Glenn Larsen
| Bedrijven | Functie | Einde |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Directeur/Bestuurslid | 18-06-2026 |
180 Therapeutics LP
 180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Engages in development of biological therapies for the treatment of fibrosis | Oprichter | 01-01-2020 |
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade Develops various drug delivery technologies | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Bestuurslid | 01-01-2010 |
Opleiding van Glenn Larsen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade Develops various drug delivery technologies | Retail Trade |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Health Technology |
180 Therapeutics LP
180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Engages in development of biological therapies for the treatment of fibrosis | Health Technology |
